Instil Bio, Inc. (TIL)
Largest Insider Buys in Sector
TIL Stock Price History Chart
TIL Stock Performance
About Instil Bio, Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 to recognize folate receptor alpha (FOLR1) with indications, including gynecological, non-small cell lung cancer, …
Insider Activity of Instil Bio, Inc.
Over the last 12 months, insiders at Instil Bio, Inc. have bought $0 and sold $0 worth of Instil Bio, Inc. stock.
On average, over the past 5 years, insiders at Instil Bio, Inc. have bought $45M and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 450,000 shares for transaction amount of $9M was made by Curative Ventures V LLC (10 percent owner) on 2021‑03‑23.
List of Insider Buy and Sell Transactions, Instil Bio, Inc.
| 2021-03-23 | 10 percent owner | 450,000 5.1249% | $20.00 | $9M | -31.22% | |||
| 2021-03-23 | CEO and Chairman | 450,000 5.1249% | $20.00 | $9M | -31.22% | |||
| 2021-03-23 | 10 percent owner | 300,000 3.4166% | $20.00 | $6M | -31.22% | |||
| 2021-03-23 | director | 300,000 3.4166% | $20.00 | $6M | -31.22% | |||
| 2021-03-23 | director | 450,000 5.1249% | $20.00 | $9M | -31.22% | |||
| 2021-03-23 | director | 300,000 3.4166% | $20.00 | $6M | -31.22% |
Insider Historical Profitability
| Curative Ventures V LLC | 10 percent owner | 37980073 581.9907% | $20.61 | 1 | 0 | <0.0001% |
| Crouch Bronson | CEO and Chairman | 37980073 581.9907% | $20.61 | 1 | 0 | <0.0001% |
| Nielsen Jack | director | 12486787 191.3423% | $20.61 | 1 | 0 | <0.0001% |
| Vivo Capital IX, LLC | 10 percent owner | 12486787 191.3423% | $20.61 | 1 | 0 | <0.0001% |
| McGaughy R Kent Jr | director | 8478790 129.9254% | $20.61 | 1 | 0 | <0.0001% |